Publication | Closed Access

Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report

Neuro-oncology2-A Preliminary ReportTumoral PathologyMalignant DiseaseMedicineImmunologyPathologyOncologyGliomaTumor MicroenvironmentMalignant Gliomas